Previous close | 0.2000 |
Open | 0.2000 |
Bid | 0.1000 |
Ask | 0.3000 |
Strike | 100.00 |
Expiry date | 2024-08-16 |
Day's range | 0.2000 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | 585 |
Fady Malik, Executive Vice President of Research & Development at Cytokinetics Inc (NASDAQ:CYTK), sold 7,788 shares of the company on June 11, 2024.
On June 10, 2024, Muna Bhanji, a Director at Cytokinetics Inc (NASDAQ:CYTK), sold 2,000 shares of the company at a price of $52.07 per share.
On June 3, 2024, B Parshall, Director at Cytokinetics Inc (NASDAQ:CYTK), executed a sale of 5,000 shares of the company.